We are live on
!
Find out more
1C
1623 Capital Portfolio holdings
AUM
$173M
1-Year Est. Return
17.08%
This Fund
S&P 500
This Quarter
Est. Return
+2.01%
1 Year Est. Return
+17.08%
3 Year Est. Return
+11.9%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$245M
AUM Growth
+$34.2M
(+16%)
Cap. Flow
+$34.8M
Cap. Flow
% of AUM
14.2%
Top 10 Holdings %
Top 10 Hldgs %
42.7%
Holding
87
New
52
Increased
10
Reduced
2
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
ASML
ASML
|
+$3.61M |
| 2 |
GFL Environmental
GFL
|
+$3.29M |
| 3 |
Pinterest
PINS
|
+$2.72M |
| 4 |
Airbnb
ABNB
|
+$2.41M |
| 5 |
Equinix
EQIX
|
+$1.24M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
American Express
AXP
|
+$5.02M |
| 2 |
Zebra Technologies
ZBRA
|
+$2.54M |
| 3 |
Verisk Analytics
VRSK
|
+$876K |
| 4 |
CME Group
CME
|
+$138K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.05% |
| 2 | Consumer Discretionary | 12.31% |
| 3 | Healthcare | 11.5% |
| 4 | Financials | 11.29% |
| 5 | Communication Services | 9.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SMAR
51
DELISTED
Smartsheet Inc.
SMAR
| $287K | 0.12% |
+4,490
| New | +$314K |
|
52
Asana
ASAN
$1.92B
| $286K | 0.12% |
+9,993
| New | +$345K |
|
|
EVBG
53
DELISTED
Everbridge, Inc. Common Stock
EVBG
| $284K | 0.12% |
+2,341
| New | +$329K |
|
|
SAIL
54
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
| $284K | 0.12% |
+5,611
| New | +$316K |
|
55
Intellia Therapeutics
NTLA
$1.49B
| $278K | 0.11% |
+3,468
| New | +$233K |
|
56
Kodiak Sciences
KOD
$2.6B
| $220K | 0.09% |
+1,942
| New | +$265K |
|
57
DexCom
DXCM
$31.5B
| $206K | 0.08% |
+2,288
| New | +$215K |
|
58
iRhythm Holdings
IRTC
$3.85B
| $193K | 0.08% |
+1,391
| New | +$249K |
|
59
Globus Medical
GMED
$10.7B
| $168K | 0.07% |
+2,724
| New | +$173K |
|
|
GTHX
60
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $162K | 0.07% |
+6,738
| New | +$157K |
|
61
Editas Medicine
EDIT
$396M
| $146K | 0.06% |
+3,481
| New | +$198K |
|
62
BioMarin Pharmaceuticals
BMRN
$11.6B
| $140K | 0.06% |
+1,852
| New | +$151K |
|
63
KALA BIO
KALA
$14.1M
| $135K | 0.06% |
+8
| New | +$156K |
|
|
TBA
64
DELISTED
Thoma Bravo Advantage
TBA
| $133K | 0.05% |
+12,739
| New | +$147K |
|
65
Precision BioSciences
DTIL
$180M
| $127K | 0.05% |
+409
| New | +$143K |
|
66
Rhythm Pharmaceuticals
RYTM
$6.81B
| $122K | 0.05% |
+5,756
| New | +$167K |
|
67
Regenxbio
RGNX
$620M
| $121K | 0.05% |
+3,533
| New | +$151K |
|
68
TSMC
TSM
$2.1T
| $101K | 0.04% |
+851
| New | +$105K |
|
69
NVIDIA
NVDA
$4.86T
| $95K | 0.04% |
+7,080
| New | +$95.2K |
|
70
Unity
U
$13.8B
| $93K | 0.04% |
+932
| New | +$115K |
|
71
Fastly Inc
FSLY
$3.55B
| $92K | 0.04% |
+1,361
| New | +$117K |
|
72
PolyPid
PYPD
$82.3M
| $83K | 0.03% |
+301
| New | +$98.1K |
|
73
Roblox
RBLX
$25.4B
| $82K | 0.03% |
+1,272
| New | +$88.7K |
|
|
TECX
74
Tectonic Therapeutic
TECX
$529M
| $77K | 0.03% |
+506
| New | +$82.3K |
|
|
DM
75
DELISTED
Desktop Metal, Inc.
DM
| $77K | 0.03% |
+520
| New | +$115K |
|
Similar funds
GA
CBC
WWP
IGWM
HWMA
RA
SWM
SVI
1623 Capital's Q1 2021 Portfolio in Review
As of Q1 2021, 1623 Capital held 87 positions worth $245M, up 16% from $211M the previous quarter. Its ten largest holdings account for 43% of the portfolio.
1623 Capital deployed $34.8M of net new capital in Q1 2021, opening 52 new positions and adding to 10 existing holdings. Its largest new stake was ASML: 6,500 shares worth $4.01M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was Zebra Technologies, an estimated $2.54M trimmed.
- 1623 Capital's largest Q1 2021 buy was ASML: 6,500 shares worth $4.01M.
- 1623 Capital added most to Pinterest in Q1 2021, an estimated $2.72M increase.
- 1623 Capital's biggest Q1 2021 reduction was Zebra Technologies, cutting an estimated $2.54M.
- 1623 Capital fully exited American Express in Q1 2021, selling an estimated $5.02M.
- 1623 Capital's ten largest holdings make up 43% of its $245M portfolio in Q1 2021.
- 1623 Capital opened 52 new positions and closed 3 in Q1 2021.
- 1623 Capital's portfolio value rose 16% quarter-over-quarter to $245M.
Based on 1623 Capital's 13F filing for Q1 2021, filed 14 May 2021.